To lead vaccine research for viral diseases of swine, including discovery of newly emerging swine viruses and providing guidance for rapid disease control response in collaboration with the transboundary and emerging viral disease team.
To build an unparalleled external network to ensure rapid adoption of relevant new technologies and ensure that BI is the preferred partner when external researchers develop new platform technologies or novel sub-unit-based vaccine candidates.
The position is accountable for building a brand new team of bacterial scientists based in Ames, Iowa. The incumbent will be responsible for developing and managing the Bacterial Disease Research Strategic Plan in collaboration with all other Innovation Division (ID) functions (BIAH, BI Human Pharma and external collaborators) aligned with ID governance processes, and the long term Animal Health business strategy. This strategy will have lasting impact on the overall portfolio value. The bacterial disease research team led by the incumbent will identify and develop ways for the control of bacterial diseases, in veterinary species. The incumbent is accountable for the discovery and development of novel entities, as well as the initiation and support of opportunities for life cycle management, prevention and control of bacterial diseases. As part of the AH Research Leadership Team, the incumbent is expected to contribute to the strategic direction and leadership of AH Research activities. The incumbent will also lead and manage the appropriate life cycle management activities collaborating with global strategic marketing.